OVERVIEW

2025 University of Illinois Cancer Center Winter CME Series - Hematologic Malignancies – Update from ASH is organized by myMedEd, Inc. and will be held on Jan 15, 2025 at Morgan's on Fulton, Chicago, Illinois, United States of America.

Description:
This conference aims to educate practitioners and update their knowledge of advances in diagnosing and managing Hematologic Malignancies.

Learning Objectives:
After participating in these activities, learners will be better able to:

  • Discuss the advancements and optimal strategies for the use of bispecific T-cell engagers and other novel therapies in Non-Hodgkin Lymphoma
  • Understand the novel advancements in CAR T Cell Therapy for Non-Hodgkin Lymphoma and Leukemias
  • Explain how to optimize treatment selection in Multiple Myeloma, including the use of minimal residual disease in the therapeutic setting
  • Recommend the latest treatment approaches in Acute Lymphoblastic and Acute Myeloid Leukemia

KEY DATES

Event Start Date
15 Jan, 2025
Event Start Date
Event End Date
15 Jan, 2025
Event End Date
Credits

Accreditation:
Physician Credit Designation
Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 3 AMA PRA Category 1 Credits™
  • TARGET AUDIENCE

    PhysicianNursingOncologyOncologistsResidentsNursesHematologistFamily PractitionersPrimary Care PractitionersAllied Health ProfessionalsFellowsMedical OncologistsAdvanced Practice Providers

    SPECIALITIES

    HaematologyOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationMorgan's on Fulton
    950 W Fulton St,

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235